Nexus Biosystems
Poway, California, United States
About Nexus Biosystems
Nexus Biosystems engages in the development and provision of technologies and automation systems for pharmaceutical, biotech, agrochemical, and academic research institutions internationally. It offers Universal Store, a sample storage and retrieval system; IRORI technologies for directed sorting and cleaving of solid-phase combinatorial chemistry libraries and synthesis products; Crystal Farm, a family of protein crystallization, incubation, and imaging products; automation solutions to automate sorting for the synthesis, cleavage, and washing steps; and synthesis manager software that controls and runs the directed sorting approach to library synthesis, as well as provides a repository for chemical building blocks and reaction procedures. The company also provides automated sorting stations; the AutoWash-10K, which is designed for washing microreactors between diversity chemistry steps; IRORI Clevap Station that automates the solvent dispensing, cleavage, transfer, and dry down process; AccuCleave Stations that offer a means to cleave compounds in batches of 96 or 192; and accessories, including dry resin fillers, tag droppers, filling kits, capping stations, LED sorting indicators, combinatorial chemistry, and crystallographic services. Nexus Biosystems, Inc. was formerly known as IRORI Discovery, Inc. The company was founded in 1996 and is based in Poway, California. As of July 25, 2011, Nexus Biosystems, Inc. operates as a subsidiary of Brooks Automation Inc.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1,001 – 5,000
- Estimated revenue: $1K – $10K
- Total funding: $5.0M
- Funding stage: M&A
- Last round: Series Unknown (Jun 2009)
- Website: nexusbio.com
- Phone: +1 858-527-7000
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/nexus-biosystems-2517421 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.